亚太地区大肠杆菌检测市场预测至 2027 年 - COVID-19 影响和区域技术分析（单克隆抗体、差异光散射、分子诊断、免疫测定、色谱、流式细胞术、凝胶微滴和诊断成像）；最终用户（商业或私人实验室、医生办公室、医院、公共卫生实验室和学术研究机构）和国家/地区 - 按技术和最终用户进行的区域分析和市场预测
No. of Pages: 133 | Report Code: TIPRE00012174 | Category: Consumer Goods
No. of Pages: 133 | Report Code: TIPRE00012174 | Category: Consumer Goods
市场介绍
大肠杆菌（E. coli）是杆状革兰氏阴性细菌。这些细菌是腹泻病的主要原因，尤其是儿童腹泻病，主要通过被动物或人类粪便污染的食物或饮用水摄入。某些大肠杆菌菌株会产生志贺毒素，导致胃肠道 (GI) 感染和医疗并发症，如胃肠道感染、胆管炎、胆囊炎、菌血症、新生儿脑膜炎和肺炎、尿路感染 (UTI)。如果不治疗，这种综合征可能会导致肾衰竭等有害结果。大肠杆菌测试用于利用粪便样本诊断胃肠道感染。这些测试可以使用分子诊断试剂盒和免疫分析进行。
市场概况和动态
亚太地区E.大肠杆菌市场预计将从 2019 年的 2.832 亿美元增至 2027 年的 4.967 亿美元。预计 2019 年和 2027 年该市场的复合年增长率将达到 7.4%。研究活动预计将促进大肠杆菌市场的增长。然而，市场可能会受到预测期内测试挑战等风险因素的影响。
关键细分市场
就技术而言，单克隆抗体领域在亚太地区占据最大份额。 2019 年公共卫生实验室市场占亚太地区最大份额。 2019 年按最终用户划分的 colitestingmarket。
主要来源和上市公司
与亚太地区相关的几个主要一手和二手来源。 colitestingmarket 报告由世界卫生组织 (WHO)、印度食品安全和标准局 (FSSAI)、澳大利亚医疗保健安全与质量委员会等机构提供。
< p>亚太地区。 COLI测试市场细分
按技术
最终用户
按国家/地区
公司简介
Strategic insights for Asia Pacific E. coli Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 283.2 Million |
| Market Size by 2027 | US$ 496.7 Million |
| Global CAGR (2019 - 2027) | 7.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific E. coli Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Asia Pacific E. coli Testing Market
The Asia Pacific E. coli Testing Market is valued at US$ 283.2 Million in 2019, it is projected to reach US$ 496.7 Million by 2027.
As per our report Asia Pacific E. coli Testing Market, the market size is valued at US$ 283.2 Million in 2019, projecting it to reach US$ 496.7 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.
The Asia Pacific E. coli Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific E. coli Testing Market report:
The Asia Pacific E. coli Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific E. coli Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific E. coli Testing Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific E. coli Testing Market
